BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30353760)

  • 1. Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea.
    Tronstad RR; Polushina T; Brattbakk HR; Stansberg C; von Volkmann HL; Hanevik K; Ellinghaus E; Jørgensen SF; Ersland KM; Pham KD; Gilja OH; Hovdenak N; Hausken T; Vatn MH; Franke A; Knappskog PM; Le Hellard S; Karlsen TH; Fiskerstrand T
    Scand J Gastroenterol; 2018; 53(10-11):1264-1273. PubMed ID: 30353760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease.
    Tronstad RR; Kummen M; Holm K; von Volkmann HL; Anmarkrud JA; Høivik ML; Moum B; Gilja OH; Hausken T; Baines J; Karlsen TH; Fiskerstrand T; Hov JR
    Inflamm Bowel Dis; 2017 Oct; 23(10):1752-1761. PubMed ID: 28902124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of guanylins are reduced in patients with Crohn's disease.
    von Volkmann HL; Brønstad I; Tronstad RR; Dizdar V; Nylund K; Hanevik K; Hausken T; Gilja OH; Fiskerstrand T
    Scand J Gastroenterol; 2020 Apr; 55(4):449-453. PubMed ID: 32306784
    [No Abstract]   [Full Text] [Related]  

  • 4. An activating gucy2c mutation causes impaired contractility and fluid stagnation in the small bowel.
    von Volkmann HL; Nylund K; Tronstad RR; Hovdenak N; Hausken T; Fiskerstrand T; Gilja OH
    Scand J Gastroenterol; 2016 Nov; 51(11):1308-15. PubMed ID: 27338166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel disease.
    Brenna Ø; Bruland T; Furnes MW; Granlund Av; Drozdov I; Emgård J; Brønstad G; Kidd M; Sandvik AK; Gustafsson BI
    Scand J Gastroenterol; 2015; 50(10):1241-52. PubMed ID: 25979109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial diarrhea syndrome caused by an activating GUCY2C mutation.
    Fiskerstrand T; Arshad N; Haukanes BI; Tronstad RR; Pham KD; Johansson S; Håvik B; Tønder SL; Levy SE; Brackman D; Boman H; Biswas KH; Apold J; Hovdenak N; Visweswariah SS; Knappskog PM
    N Engl J Med; 2012 Apr; 366(17):1586-95. PubMed ID: 22436048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation.
    von Volkmann HL; Brønstad I; Gilja OH; R Tronstad R; Sangnes DA; Nortvedt R; Hausken T; Dimcevski G; Fiskerstrand T; Nylund K
    PLoS One; 2017; 12(9):e0185496. PubMed ID: 28957388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic profile of patients with early onset inflammatory bowel disease.
    Girardelli M; Basaldella F; Paolera SD; Vuch J; Tommasini A; Martelossi S; Crovella S; Bianco AM
    Gene; 2018 Mar; 645():18-29. PubMed ID: 29248579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C.
    Müller T; Rasool I; Heinz-Erian P; Mildenberger E; Hülstrunk C; Müller A; Michaud L; Koot BG; Ballauff A; Vodopiutz J; Rosipal S; Petersen BS; Franke A; Fuchs I; Witt H; Zoller H; Janecke AR; Visweswariah SS
    Gut; 2016 Aug; 65(8):1306-13. PubMed ID: 25994218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
    Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
    J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease.
    Rufini S; Ciccacci C; Di Fusco D; Ruffa A; Pallone F; Novelli G; Biancone L; Borgiani P
    Dig Liver Dis; 2015 Sep; 47(9):744-50. PubMed ID: 26066377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes.
    Lin Z; Hegarty JP; John G; Berg A; Wang Z; Sehgal R; Pastor DM; Wang Y; Harris LR; Poritz LS; Schreiber S; Koltun WA
    Dig Dis Sci; 2013 Sep; 58(9):2599-607. PubMed ID: 23709157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between nucleotide oligomerisation domain two (Nod2) gene polymorphisms and canine inflammatory bowel disease.
    Kathrani A; Lee H; White C; Catchpole B; Murphy A; German A; Werling D; Allenspach K
    Vet Immunol Immunopathol; 2014 Sep; 161(1-2):32-41. PubMed ID: 25017709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico.
    Ballester V; Guo X; Vendrell R; Haritunians T; Klomhaus AM; Li D; McGovern DP; Rotter JI; Torres EA; Taylor KD
    PLoS One; 2014; 9(9):e108204. PubMed ID: 25259511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease genetics: Nod2.
    Cho JH; Abraham C
    Annu Rev Med; 2007; 58():401-16. PubMed ID: 16987083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the NOD2/CARD15 gene in patients affected with the aseptic abscesses syndrome with or without inflammatory bowel disease.
    André MF; Aumaître O; Piette JC; Grateau G; Cardoso MC; Ouchchane L; Kémény JL; Dastugue B; Delpech M; Creveaux I
    Dig Dis Sci; 2008 Feb; 53(2):490-9. PubMed ID: 17570063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.